Free Trial
NASDAQ:TTRX

Turn Therapeutics Q2 2026 Earnings Results & Report

Turn Therapeutics logo
$8.59 -0.76 (-8.14%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Turn Therapeutics reported Q2 2026 earnings on August 12, 2026. The company reported EPS of -$0.20.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes
Conference Call
4:00 PM ET

Turn Therapeutics EPS Results

Actual EPS
-$0.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Turn Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Turn Therapeutics Q2 2026 Earnings FAQ

Turn Therapeutics (NASDAQ:TTRX) reported earnings of -$0.20 per share for Q2 2026. The report was announced on Wednesday, August 12, 2026.

Turn Therapeutics Earnings Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Turn Therapeutics Inc. GAAP EPS of -$0.21
See More Turn Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Turn Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turn Therapeutics and other key companies, straight to your email.

About Turn Therapeutics

Turn Therapeutics (NASDAQ:TTRX) is a biotechnology company focused on developing topical products for skin health, wound care and infection management. Its work centers on formulations intended to deliver antimicrobial treatment directly to affected areas.

The company has developed products for wound care and other topical applications, using its formulation technology to address needs in dermatology and related fields. Turn Therapeutics is based in the United States and has focused on developing and commercializing its products in the U.S. market.

View Turn Therapeutics Profile